NO20020777L - Farmasöytiske preparater inneholdende derivater og fremgangsmåte for fremstilling derav - Google Patents
Farmasöytiske preparater inneholdende derivater og fremgangsmåte for fremstilling deravInfo
- Publication number
- NO20020777L NO20020777L NO20020777A NO20020777A NO20020777L NO 20020777 L NO20020777 L NO 20020777L NO 20020777 A NO20020777 A NO 20020777A NO 20020777 A NO20020777 A NO 20020777A NO 20020777 L NO20020777 L NO 20020777L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pharmaceutical preparations
- preparations containing
- containing derivatives
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9919465.6A GB9919465D0 (en) | 1999-08-17 | 1999-08-17 | Novel compounds |
GBGB9919842.6A GB9919842D0 (en) | 1999-08-20 | 1999-08-20 | Novel compounds |
GBGB9920149.3A GB9920149D0 (en) | 1999-08-25 | 1999-08-25 | Novel compounds |
PCT/EP2000/007926 WO2001012628A1 (en) | 1999-08-17 | 2000-08-14 | Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20020777D0 NO20020777D0 (no) | 2002-02-15 |
NO20020777L true NO20020777L (no) | 2002-02-15 |
Family
ID=27269792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20020777A NO20020777L (no) | 1999-08-17 | 2002-02-15 | Farmasöytiske preparater inneholdende derivater og fremgangsmåte for fremstilling derav |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1202991A1 (hu) |
JP (1) | JP2003507379A (hu) |
KR (1) | KR20020022812A (hu) |
CN (1) | CN1379776A (hu) |
AU (1) | AU7408900A (hu) |
BR (1) | BR0013375A (hu) |
CA (1) | CA2381976A1 (hu) |
CZ (1) | CZ2002531A3 (hu) |
HU (1) | HUP0202438A2 (hu) |
IL (1) | IL148164A0 (hu) |
MX (1) | MXPA02001716A (hu) |
NO (1) | NO20020777L (hu) |
PL (1) | PL353886A1 (hu) |
TR (1) | TR200200438T2 (hu) |
WO (1) | WO2001012628A1 (hu) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1284291A4 (en) * | 2000-05-25 | 2005-06-08 | Yamanouchi Pharma Co Ltd | PROMOTER OF HUMAN PGC-1 |
WO2003029251A1 (en) * | 2001-09-28 | 2003-04-10 | Biocon Limited | Novel process for the synthesis of thiazolidinedione derivatives |
GB0129871D0 (en) * | 2001-12-13 | 2002-02-06 | Smithkline Beecham Plc | Novel pharmaceutical |
GB0130509D0 (en) * | 2001-12-20 | 2002-02-06 | Smithkline Beecham Plc | Novel pharmaceutical |
KR100450700B1 (ko) * | 2002-03-22 | 2004-10-01 | 주식회사종근당 | 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물 |
KR20050068860A (ko) | 2003-12-30 | 2005-07-05 | 엘지.필립스 엘시디 주식회사 | 듀얼 플레이트 유기전계 발광소자용 상부기판 및 그의제조방법 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3856378T2 (de) * | 1987-09-04 | 2000-05-11 | Beecham Group P.L.C., Brentford | Substituierte Thiazolidindionderivate |
GB8919417D0 (en) * | 1989-08-25 | 1989-10-11 | Beecham Group Plc | Novel compounds |
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
EP0777469A1 (en) * | 1994-02-10 | 1997-06-11 | Smithkline Beecham Plc | Use of insulin sensitisers for treating renal diseases |
-
2000
- 2000-08-14 HU HU0202438A patent/HUP0202438A2/hu unknown
- 2000-08-14 BR BR0013375-2A patent/BR0013375A/pt not_active IP Right Cessation
- 2000-08-14 AU AU74089/00A patent/AU7408900A/en not_active Abandoned
- 2000-08-14 PL PL00353886A patent/PL353886A1/xx not_active Application Discontinuation
- 2000-08-14 MX MXPA02001716A patent/MXPA02001716A/es unknown
- 2000-08-14 CA CA002381976A patent/CA2381976A1/en not_active Abandoned
- 2000-08-14 JP JP2001517526A patent/JP2003507379A/ja active Pending
- 2000-08-14 TR TR2002/00438T patent/TR200200438T2/xx unknown
- 2000-08-14 KR KR1020027002026A patent/KR20020022812A/ko not_active Application Discontinuation
- 2000-08-14 IL IL14816400A patent/IL148164A0/xx unknown
- 2000-08-14 EP EP00962315A patent/EP1202991A1/en not_active Withdrawn
- 2000-08-14 WO PCT/EP2000/007926 patent/WO2001012628A1/en not_active Application Discontinuation
- 2000-08-14 CN CN00814298A patent/CN1379776A/zh active Pending
- 2000-08-14 CZ CZ2002531A patent/CZ2002531A3/cs unknown
-
2002
- 2002-02-15 NO NO20020777A patent/NO20020777L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL148164A0 (en) | 2002-09-12 |
JP2003507379A (ja) | 2003-02-25 |
TR200200438T2 (tr) | 2002-05-21 |
NO20020777D0 (no) | 2002-02-15 |
AU7408900A (en) | 2001-03-13 |
CZ2002531A3 (cs) | 2002-07-17 |
BR0013375A (pt) | 2002-07-23 |
PL353886A1 (en) | 2003-12-01 |
CN1379776A (zh) | 2002-11-13 |
HUP0202438A2 (hu) | 2002-12-28 |
EP1202991A1 (en) | 2002-05-08 |
WO2001012628A1 (en) | 2001-02-22 |
MXPA02001716A (es) | 2002-08-06 |
KR20020022812A (ko) | 2002-03-27 |
CA2381976A1 (en) | 2001-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20021401D0 (no) | Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser | |
NO20001409D0 (no) | Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger | |
EE200100431A (et) | 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine | |
HUP0201711A3 (en) | N-indanyl-benzamide derivatives, method for their production, their use and pharmaceutical preparations containing them | |
NO20016277D0 (no) | Systemer og fremgangsmåter for aerolisering av farmasöytiske formuleringer | |
NO20013736L (no) | Pyrazolkarboksylsyrederivater, deres fremstilling og farmasöytiske preparater inneholdende de samme | |
DK1202965T3 (da) | Indolderivater, fremgangsmåde til fremstilling deraf, farmaceutiske præparater indeholdende disse og deres medicinske anvendelse | |
NO20002835L (no) | 2-aryl-oksodihydropurinderivater, fremgangsmÕte for fremstilling av disse medisinske preparater inneholdende disse, og mellomprodukter derfor | |
NO985368L (no) | Substituerte imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende forbindelsene | |
ATE332132T1 (de) | Verbesserte arzneizubereitungen enthaltend ritonavir | |
NO984309D0 (no) | Nye imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende disse | |
NO20015659L (no) | Purinderivater, fremstillingsmetode og farmasöytiske preparater inneholdende disse | |
EE200100422A (et) | Epotilooni derivaadid, nende valmistamismeetod jafarmatseutiline kasutamine | |
NO20003662D0 (no) | Syntetiske polysakkarider, fremgangsmÕte for fremstilling derav og farmasøytiske preparater inneholdende slike | |
NO994659D0 (no) | Nye pyridinderivater og farmasöytiske preparater inneholdende slike | |
EE200300135A (et) | Trüptamiini derivaadid ja analoogsed ühendid ningneid sisaldavad farmatseutilised preparaadid | |
NO930796D0 (no) | Glykopeptidderivater, fremgangsmaate for deres fremstilling og farmasoeytiske midler inneholdende disse | |
NO20013878L (no) | (1-fenacy-3-fenyl-3-piperidylety)piperidinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparaterinneholdende de samme | |
NO20020777D0 (no) | Farmasöytiske preparater inneholdende derivater og fremgangsmåte for fremstilling derav | |
NO20014803D0 (no) | Pyrido-tieno-diazepiner, fremgangsmåte for fremstilling derav og farmasöytiske blandinger inneholdende dem | |
NO20014632D0 (no) | Nye morfolinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparater inneholdende de nevnte derivater | |
NO20013141D0 (no) | Arylalkanoylderivater, fremgangsmåte for fremstilling derav, deres anvendelse og farmasöytiske produkter inneholdende disse | |
PT1206253E (pt) | Preparacoes farmaceuticas solidas contendo nanossois de quitosano e metodo de preparacao | |
NO20031841D0 (no) | Triazolderivater og farmasöytiske preparater inneholdende disse | |
NO20024823L (no) | Medisinske preparater inneholdende camptothecin-derivat og pH regulerende middel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |